Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer

Colorectal cancer (CRC) is one of the most common and recurrent types of cancer, with high mortality rates. Several clinical trials and meta-analyses have determined that the use of pharmacological inhibitors of cyclooxygenase 2 (COX-2), the enzyme that catalyses the rate-limiting step in the synthe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hidalgo-Estévez, Alicia M., Stamatakis, Konstantinos, Jiménez-Martínez, Marta, López-Pérez, Ricardo, Fresno, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201075/
https://www.ncbi.nlm.nih.gov/pubmed/32410997
http://dx.doi.org/10.3389/fphar.2020.00533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201075/
https://www.ncbi.nlm.nih.gov/pubmed/32410997
http://dx.doi.org/10.3389/fphar.2020.00533

Ejemplares similares